Search This Blog

Thursday, July 25, 2019

NovoCure EPS beats by $0.06, beats on revenue

NovoCure (NASDAQ:NVCR): Q2 GAAP EPS of -$0.01 beats by $0.06.
Revenue of $86.71M (+41.0% Y/Y) beats by $7.73M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)